Pular para o conteúdo
Merck
  • Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.

Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.

Antimicrobial agents and chemotherapy (2008-09-17)
Nathan P Wiederhold, Jodi L Grabinski, Guillermo Garcia-Effron, David S Perlin, Samuel A Lee
RESUMO

Pyrosequencing was compared to Sanger dideoxy sequencing to detect mutations in FKS1 responsible for reduced echinocandin susceptibility in Candida albicans. These methods were in complete agreement for 10 of 12 clinical isolates with elevated echinocandin MICs, supporting the potential feasibility of pyrosequencing to detect mutations within diploid fungi.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Soro humano, from human male AB plasma, USA origin, sterile-filtered
Sigma-Aldrich
Soro humano, Heat Inactivated, from human male AB plasma, USA origin, sterile-filtered
Sigma-Aldrich
Soro humano, (from male AB clotted whole blood), USA origin, sterile-filtered
Sigma-Aldrich
Soro humano, Heat Inactivated (from male AB clotted whole blood), USA origin, sterile-filtered
Sigma-Aldrich
Soro humano, from platelet poor human plasma, sterile-filtered, (mycoplasma tested, virus tested)